Search
Now showing items 1-10 of 10
Wnt/β-Catenin signaling as a driver of hepatocellular carcinoma progression: an emphasis on molecular pathways
(Dove Medical Press, 2021)
Liver cancers cause a high rate of death worldwide and hepatocellular carcinoma (HCC) is considered as the most common primary liver cancer. HCC remains a challenging disease to treat. Wnt/β-catenin signaling pathway is ...
EZH2 as a new therapeutic target in brain tumors: Molecular landscape, therapeutic targeting and future prospects
(Elsevier, 2022)
Brain tumors are responsible for high mortality and morbidity worldwide. The brain tumor treatment depends on identification of molecular pathways involved in progression and malignancy. Enhancer of zeste homolog 2 (EZH2) ...
Targeting cancer stem cells by dietary agents: an important therapeutic strategy against human malignancies
(MDPI, 2021)
As a multifactorial disease, treatment of cancer depends on understanding unique mechanisms involved in its progression. The cancer stem cells (CSCs) are responsible for tumor stemness and by enhancing colony formation, ...
Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy
(2022)
Gene therapy can be used as a cancer therapy by affecting signaling networks participating in the aggressive behavior of tumors. Small interfering RNA (siRNA) is a genetic tool employed for gene silencing. The siRNA molecules ...
Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance
(2022)
Introduction: The application of doxorubicin (DOX) in cancer therapy has been limited due to its drug resistance and poor internalization. Graphene oxide (GO) nanostructures have the capacity for DOX delivery while promoting ...
Non-coding RNAs and macrophage interaction in tumor progression
(Elsevier Ireland Ltd, 2022)
The macrophages are abundantly found in TME and their M2 polarization is in favor of tumor malignancy. On the other hand, non-coding RNAs (ncRNAs) can modulate macrophage polarization in TME to affect cancer progression. ...
Molecular landscape of LncRNAs in prostate cancer: A focus on pathways and therapeutic targets for intervention
(PMC, 2022)
Background: One of the most malignant tumors in men is prostate cancer that is still incurable due to its heterog‑
enous and progressive natures. Genetic and epigenetic changes play signifcant roles in its development. ...
Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches
(Elsevier, 2022)
The site-specific delivery of antitumor agents is of importance for providing effective cancer suppression. Poor bioavailability of anticancer compounds and the presence of biological barriers prevent their accumulation ...
Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action
(Springer Science and Business Media Deutschland GmbH, 2022)
Breast cancer (BC) is one of the most common cancers in females and is responsible for the highest cancer-related deaths following lung cancer. The complex tumor microenvironment and the aggressive behavior, heterogenous ...
Pre-clinical and clinical importance of mir-21 in human cancers: tumorigenesis, therapy response, delivery approaches and targeting agents
(ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, 2023)
The field of non-coding RNA (ncRNA) has made significant progress in understanding the pathogenesis of diseases and has broadened our knowledge towards their targeting, especially in cancer therapy. ncRNAs are a large ...